{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:42:08Z","timestamp":1766580128272,"version":"3.41.2"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372172"],"award-info":[{"award-number":["82372172"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Initial choices of antimicrobial therapy for most cases of community-acquired pneumonia (CAP) in children under 5 years of age are typically based on local epidemiology, risk factors assessment, and subsequent clinical parameters and positive cultures, which can lead to the underdiagnosis and underestimation of lung infections caused by uncommon pathogens. Contezolid, an orally administered oxazolidinone antibiotic, gained approval from the National Medical Products Administration (NMPA) of China in June 2021 for managing complicated skin and soft tissue infections (cSSTI) caused by staphylococcus aureus (SA), streptococcus pyogenes, or streptococcus agalactis. Owing to its enhanced safety profile and ongoing clinical progress, the scope of contezolid's clinical application continues to expand, benefiting a growing number of patients with Gram-positive bacterial infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case summary<\/jats:title><jats:p>In this report, we present the first use of contezolid in a toddler with severe CAP caused by SA, aiming to avoid potential adverse drug reactions (ADRs) associated with vancomycin and linezolid.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although contezolid has not been officially indicated for CAP, it has been shown to be effective and safe in the management of SA-induced severe CAP in this toddler, suggesting its potential as an alternative option in the dilemma, especially for patients who are susceptible or intolerant to ADRs associated with first-line anti-methicillin-resistant staphylococcus aureus (MRSA) antimicrobial agents.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2024.1321447","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T05:19:52Z","timestamp":1707283192000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Compassionate use of contezolid in a toddler with severe community-acquired pneumonia induced by staphylococcus aureus: a case report and follow-up"],"prefix":"10.3389","volume":"12","author":[{"given":"Hui-Ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Fei","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Jie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Cheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Lu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Qiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Xiao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.earlhumdev.2013.07.023","article-title":"Community-acquired pneumonia in children","volume":"89","author":"Cardinale","year":"2013","journal-title":"Early Hum Dev"},{"key":"B2","first-page":"625","article-title":"Community-acquired pneumonia in adults: rapid evidence review","volume":"105","author":"Womack","year":"2022","journal-title":"Am Fam Physician"},{"key":"B3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2174\/1872213X12666180621163821","article-title":"Community-acquired pneumonia in children","volume":"12","author":"Leung","year":"2018","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1080\/21645515.2017.1371381","article-title":"The etiology of community-acquired pneumonia among children under 5 years of age in Mainland China, 2001\u20132015: a systematic review","volume":"13","author":"Ning","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"B5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jped.2019.08.003","article-title":"Community-acquired pneumonia among children: the latest evidence for an updated management","volume":"96","author":"Nascimento-Carvalho","year":"2020","journal-title":"J Pediatr (Rio J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/INF.0000000000003475","article-title":"Clinical characteristics and etiology of community-acquired pneumonia in US children, 2015\u20132018","volume":"41","author":"Yun","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1055\/s-0039-1691801","article-title":"Community-acquired pneumonia in children: myths and facts","volume":"36","author":"Yun","year":"2019","journal-title":"Am J Perinatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00134-019-05519-y","article-title":"Challenges in severe community-acquired pneumonia: a point-of-view review","volume":"45","author":"Torres","year":"2019","journal-title":"Intensive Care Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e394","DOI":"10.1097\/CCM.0000000000003658","article-title":"Enhanced performance of next-generation sequencing diagnostics compared with standard of care microbiological diagnostics in patients suffering from septic shock","volume":"47","author":"Grumaz","year":"2019","journal-title":"Crit Care Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1186\/s12879-021-06923-w","article-title":"Metagenomic next-generation sequencing in the diagnosis of leptospirosis presenting as severe diffuse alveolar hemorrhage: a case report and literature review","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1097\/INF.0000000000003503","article-title":"Staphylococcus aureus community-acquired pneumonia in children after 13-valent pneumococcal vaccination (2008\u20132018): epidemiology, clinical characteristics and outcomes","volume":"41","author":"Aguilera-Alonso","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1055\/s-0040-1709992","article-title":"Staphylococcus aureus pneumonia in the community","volume":"41","author":"He","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"18670","DOI":"10.1038\/s41598-022-23246-1","article-title":"Characteristics and local risk factors of community-acquired and health-care-associated Staphylococcus aureus pneumonia","volume":"12","author":"Lee","year":"2022","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jinf.2020.10.032","article-title":"Methicillin-susceptible staphylococcus aureus in community-acquired pneumonia: risk factors and outcomes","volume":"82","author":"Cilloniz","year":"2021","journal-title":"J Infect"},{"key":"B15","doi-asserted-by":"publisher","first-page":"993923","DOI":"10.3389\/fphar.2022.993923","article-title":"Drug-induced kidney injury in Chinese critically ill pediatric patients","volume":"13","author":"Hu","year":"2022","journal-title":"Front Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s12519-022-00650-1","article-title":"Safety and clinical efficacy of linezolid in children: a systematic review and meta-analysis","volume":"19","author":"Shi","year":"2023","journal-title":"World J Pediatr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s40265-021-01576-0","article-title":"Contezolid: first approval","volume":"81","author":"Hoy","year":"2021","journal-title":"Drugs"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1157437","DOI":"10.3389\/fphar.2023.1157437","article-title":"Contezolid, a novel oxazolidinone antibiotic, may improve drug-related thrombocytopenia in clinical antibacterial treatment","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.2147\/IDR.S413452","article-title":"Use of contezolid for the treatment of refractory infective endocarditis in a patient with chronic renal failure: case report","volume":"16","author":"Zhao","year":"2023","journal-title":"Infect Drug Resist"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2147\/IDR.S401533","article-title":"Sequential therapy of linezolid and contezolid to treat vancomycin-resistant Enterococcus faecium pneumonia in a centenarian patient: case report","volume":"16","author":"Chen","year":"2023","journal-title":"Infect Drug Resist"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.2147\/IDR.S406799","article-title":"Severe community-acquired pneumonia caused by methicillin-sensitive Staphylococcus aureus: successfully treated with contezolid - A case report and literature review","volume":"16","author":"Wang","year":"2023","journal-title":"Infect Drug Resist"},{"key":"B22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.prrv.2022.01.006","article-title":"Systematic review of clinical practice guidelines on the management of community acquired pneumonia in children","volume":"42","author":"Chee","year":"2022","journal-title":"Paediatr Respir Rev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/14656566.2018.1552257","article-title":"Clinical management of community-acquired pneumonia in young children","volume":"20","author":"Nascimento-Carvalho","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"B24","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S2352-4642(22)00092-X","article-title":"Prevalence of respiratory viruses in community-acquired pneumonia in children: a systematic review and meta-analysis","volume":"6","author":"Pratt","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12887-022-03235-z","article-title":"Etiology and the challenge of diagnostic testing of community-acquired pneumonia in children and adolescents","volume":"22","author":"Rueda","year":"2022","journal-title":"BMC Pediatr"},{"key":"B26","doi-asserted-by":"publisher","first-page":"fmac111","DOI":"10.1093\/tropej\/fmac111","article-title":"Epidemiological characteristics of community-acquired pneumonia and effects from the COVID-19 pandemic in Shenzhen of China","volume":"69","author":"Cheng","year":"2022","journal-title":"J Trop Pediatr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12879-022-07263-z","article-title":"Analysis of national surveillance of respiratory pathogens for community-acquired pneumonia in children and adolescents","volume":"22","author":"Roh","year":"2022","journal-title":"BMC Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/medicina59040760","article-title":"Prevalence and etiology of community- and hospital-acquired pneumonia in Saudi Arabia and their antimicrobial susceptibility patterns: a systematic review","volume":"59","author":"Alshammari","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1075185","DOI":"10.3389\/fcimb.2022.1075185","article-title":"A multicenter investigation of 2,773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET)","volume":"12","author":"Hu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12098-019-03123-y","article-title":"Pediatric blood cultures and antibiotic resistance: an overview","volume":"87","author":"Wattal","year":"2020","journal-title":"Indian J Pediatr"},{"key":"B31","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(20)31550-6","article-title":"Complicated pneumonia in children","volume":"396","author":"de Benedictis","year":"2020","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fcimb.2019.00170","article-title":"Prevalence of panton-valentine leukocidin (PVL) and antimicrobial resistance in community-acquired clinical Staphylococcus aureus in an urban gambian hospital: a 11-year period retrospective pilot study","volume":"9","author":"Darboe","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/antibiotics12040742","article-title":"New antibiotics for staphylococcus aureus infection: an update from the world association of infectious diseases and immunological disorders (WAidid) and the Italian society of anti-infective therapy (SITA)","volume":"12","author":"Esposito","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1111\/apa.14670","article-title":"Paediatric community-acquired bacteraemia, pneumococcal invasive disease and antibiotic resistance fell after the pneumococcal conjugate vaccine was introduced","volume":"108","author":"Berger","year":"2019","journal-title":"Acta Paediatr"},{"key":"B35","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1093\/cid\/ciz463","article-title":"Community-acquired invasive bacterial disease in Urban Gambia, 2005\u20132015: a hospital-based surveillance","volume":"69","author":"Darboe","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e20183090","DOI":"10.1542\/peds.2018-3090","article-title":"Prevalence, risk factors, and outcomes of bacteremic pneumonia in children","volume":"144","author":"Fritz","year":"2019","journal-title":"Pediatrics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.ijid.2022.07.054","article-title":"Diagnostic performance of metagenomic next-generation sequencing for the detection of pathogens in bronchoalveolar lavage fluid in patients with pulmonary infections: systematic review and meta-analysis","volume":"122","author":"Chen","year":"2022","journal-title":"Int J Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0148822","DOI":"10.1128\/spectrum.01488-22","article-title":"Application of metagenomic next-generation sequencing (mNGS) using bronchoalveolar lavage fluid (BALF) in diagnosing pneumonia of children","volume":"10","author":"Yang","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e20562","DOI":"10.1016\/j.heliyon.2023.e20562","article-title":"Successful treatment of near-fatal pulmonary embolism and cardiac arrest in an adult patient with fulminant psittacosis-induced severe acute respiratory distress syndrome after veno-venous extracorporeal membrane oxygenation rescue: a case report and follow-up","volume":"9","author":"Yang","year":"2023","journal-title":"Heliyon"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1177\/08850666221085181","article-title":"A standardized step-by-step approach for the diagnosis and treatment of sepsis","volume":"37","author":"Gao","year":"2022","journal-title":"J Intensive Care Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/QCO.0000000000000526","article-title":"New antibiotics for community-acquired pneumonia","volume":"32","author":"Kollef","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1358\/2022.58.7.3389002","article-title":"Contezolid in complicated skin and soft tissue infection","volume":"58","author":"Kaul","year":"2022","journal-title":"Drugs Today (Barc)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1021\/acs.chemrestox.0c00524","article-title":"Nonclinical evaluation of antibacterial oxazolidinones contezolid and contezolid acefosamil with low serotonergic neurotoxicity","volume":"34","author":"Wang","year":"2021","journal-title":"Chem Res Toxicol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/jac\/dkac073","article-title":"A phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections","volume":"77","author":"Zhao","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e01195","DOI":"10.1128\/AAC.01195-20","article-title":"In vitro activity and potency of the novel oxazolidinone contezolid (MRX-I) tested against gram-positive clinical isolates from the United States and Europe","volume":"64","author":"Carvalhaes","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408347.2023.2228902","article-title":"Analytical methodologies for the estimation of oxazolidinone antibiotics as key members of anti-MRSA arsenal: a decade in review","author":"El-Kimary","year":"2023","journal-title":"Crit Rev Anal Chem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"106875","DOI":"10.1016\/j.ijantimicag.2023.106875","article-title":"Concentration of contezolid in cerebrospinal fluid and serum in a patient with tuberculous meningoencephalitis: a case report","volume":"62","author":"Guo","year":"2023","journal-title":"Int J Antimicrob Agents"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1321447\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T05:20:00Z","timestamp":1707283200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1321447\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,7]]},"references-count":47,"alternative-id":["10.3389\/fped.2024.1321447"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1321447","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2024,2,7]]},"article-number":"1321447"}}